These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25407584)

  • 1. Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an "individual patient data" meta-analysis.
    Cuijpers P; Weitz E; Twisk J; Kuehner C; Cristea I; David D; DeRubeis RJ; Dimidjian S; Dunlop BW; Faramarzi M; Hegerl U; Jarrett RB; Kennedy SH; Kheirkhah F; Mergl R; Miranda J; Mohr DC; Segal ZV; Siddique J; Simons AD; Vittengl JR; Hollon SD
    Depress Anxiety; 2014 Nov; 31(11):941-51. PubMed ID: 25407584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis.
    Weitz ES; Hollon SD; Twisk J; van Straten A; Huibers MJ; David D; DeRubeis RJ; Dimidjian S; Dunlop BW; Cristea IA; Faramarzi M; Hegerl U; Jarrett RB; Kheirkhah F; Kennedy SH; Mergl R; Miranda J; Mohr DC; Rush AJ; Segal ZV; Siddique J; Simons AD; Vittengl JR; Cuijpers P
    JAMA Psychiatry; 2015 Nov; 72(11):1102-9. PubMed ID: 26397232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety?
    Roshanaei-Moghaddam B; Pauly MC; Atkins DC; Baldwin SA; Stein MB; Roy-Byrne P
    Depress Anxiety; 2011 Jul; 28(7):560-7. PubMed ID: 21608087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression.
    Vittengl JR; Jarrett RB; Weitz E; Hollon SD; Twisk J; Cristea I; David D; DeRubeis RJ; Dimidjian S; Dunlop BW; Faramarzi M; Hegerl U; Kennedy SH; Kheirkhah F; Mergl R; Miranda J; Mohr DC; Rush AJ; Segal ZV; Siddique J; Simons AD; Cuijpers P
    Am J Psychiatry; 2016 May; 173(5):481-90. PubMed ID: 26869246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melancholic and atypical depression as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression.
    Cuijpers P; Weitz E; Lamers F; Penninx BW; Twisk J; DeRubeis RJ; Dimidjian S; Dunlop BW; Jarrett RB; Segal ZV; Hollon SD
    Depress Anxiety; 2017 Mar; 34(3):246-256. PubMed ID: 27921338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care: a randomized controlled trial.
    Serfaty MA; Haworth D; Blanchard M; Buszewicz M; Murad S; King M
    Arch Gen Psychiatry; 2009 Dec; 66(12):1332-40. PubMed ID: 19996038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of binge eating disorder.
    Wilson GT
    Psychiatr Clin North Am; 2011 Dec; 34(4):773-83. PubMed ID: 22098803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.
    Barber JP; Barrett MS; Gallop R; Rynn MA; Rickels K
    J Clin Psychiatry; 2012 Jan; 73(1):66-73. PubMed ID: 22152401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of cognitive-behavioural therapy plus pharmacotherapy in inpatient treatment of depressive disorders.
    Köhler S; Hoffmann S; Unger T; Steinacher B; Dierstein N; Fydrich T
    Clin Psychol Psychother; 2013; 20(2):97-106. PubMed ID: 22095701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC
    Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of men with major depression: a comparison of sequential cohorts treated with either cognitive-behavioral therapy or newer generation antidepressants.
    Thase ME; Friedman ES; Fasiczka AL; Berman SR; Frank E; Nofzinger EA; Reynolds CF
    J Clin Psychiatry; 2000 Jul; 61(7):466-72. PubMed ID: 10937603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual patient data meta-analysis of combined treatments versus psychotherapy (with or without pill placebo), pharmacotherapy or pill placebo for adult depression: a protocol.
    Weitz E; Kleiboer A; van Straten A; Hollon SD; Cuijpers P
    BMJ Open; 2017 Feb; 7(2):e013478. PubMed ID: 28193851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the cognitive mediational model of cognitive behavioural therapy for depression.
    Quilty LC; McBride C; Bagby RM
    Psychol Med; 2008 Nov; 38(11):1531-41. PubMed ID: 18578895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
    Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
    J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-criticism predicts differential response to treatment for major depression.
    Marshall MB; Zuroff DC; McBride C; Bagby RM
    J Clin Psychol; 2008 Mar; 64(3):231-44. PubMed ID: 18302208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice.
    van der Lem R; van der Wee NJ; van Veen T; Zitman FG
    Psychother Psychosom; 2012; 81(4):226-34. PubMed ID: 22584117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial of cognitive behaviour therapy vs treatment as usual in the treatment of mild to moderate late life depression.
    Laidlaw K; Davidson K; Toner H; Jackson G; Clark S; Law J; Howley M; Bowie G; Connery H; Cross S
    Int J Geriatr Psychiatry; 2008 Aug; 23(8):843-50. PubMed ID: 18311844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy.
    Pinquart M; Duberstein PR; Lyness JM
    Am J Psychiatry; 2006 Sep; 163(9):1493-501. PubMed ID: 16946172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Depression Treatment Response in an Intensive CBT Partial Hospital.
    Beard C; Stein AT; Hearon BA; Lee J; Hsu KJ; Björgvinsson T
    J Clin Psychol; 2016 Apr; 72(4):297-310. PubMed ID: 26934333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.